Magnetic Resonance Imaging in a Neurofibromatosis Type 2 Patient with a Novel MRI-Compatible Auditory Brainstem Implant

Abstract

Auditory brainstem implantation has become a key technique for the rehabilitation of hearing in patients with neurofibromatosis type 2. The nature of this devastating genetic disease requires ongoing MRI for the patient's lifespan. Today, most auditory brainstem implants require removal of the magnet that connects the internal device to the external speech processor to undergo imaging as their disease progresses. Patients have the option of having a short procedure to have the magnet taken out and replaced each time, or alternately using a headband to secure the processor over the receiver coil of the internal device. Novel magnet technology has led to the development of a freely rotating magnet that can be used inside the magnetic field of an MRI scanner without losing magnet strength and without being displaced from the body of the device. We report one of the first patients implanted with a Med-El Synchrony ABI in the United States who subsequently underwent successful imaging with MRI 1.5 tesla to follow for other existing schwannomas.

Keywords

neurofibromatosis type 2 - auditory brainstem implant - magnetic resonance imaging

Note

The authors have no funding, financial relationships, or conflicts of interest to disclose.

• References

• 1 Edgerton BJ, House WF, Hitselberger W. Hearing by cochlear nucleus stimulation in humans. Ann Otol Rhinol Laryngol Suppl 1982; 91 (2 Pt 3): 117-124
• 2 Heller JW, Brackmann DE, Tucci DL, Nyenhuis JA, Chou CK. Evaluation of MRI compatibility of the modified nucleus multichannel auditory brainstem and cochlear implants. Am J Otol 1996; 17 (05) 724-729
• 3 Neary WJ, Hillier VF, Flute T, Stephens D, Ramsden RT, Evans DG. Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. J Laryngol Otol 2010; 124 (07) 720-728
• 4 Patel CM, Ferner R, Grunfeld EA. A qualitative study of the impact of living with neurofibromatosis type 2. Psychol Health Med 2011; 16 (01) 19-28
• 5 Portnoy WM, Mattucci K. Cochlear implants as a contraindication to magnetic resonance imaging. Ann Otol Rhinol Laryngol 1991; 100 (03) 195-197
• 6 Teissl C, Kremser C, Hochmair ES, Hochmair-Desoyer IJ. Magnetic resonance imaging and cochlear implants: compatibility and safety aspects. J Magn Reson Imaging 1999; 9 (01) 26-38
• 7 Azadarmaki R, Tubbs R, Chen DA, Shellock FG. MRI information for commonly used otologic implants: review and update. Otolaryngol Head Neck Surg 2014; 150 (04) 512-519
• 8 Migirov L, Wolf M. Magnet removal and reinsertion in a cochlear implant recipient undergoing brain MRI. ORL J Otorhinolaryngol Relat Spec 2013; 75 (01) 1-5
• 9 Gubbels SP, McMenomey SO. Safety study of the Cochlear Nucleus 24 device with internal magnet in the 1.5 tesla magnetic resonance imaging scanner. Laryngoscope 2006; 116 (06) 865-871
• 10 Crane BT, Gottschalk B, Kraut M, Aygun N, Niparko JK. Magnetic resonance imaging at 1.5 T after cochlear implantation. Otol Neurotol 2010; 31 (08) 1215-1220
• 11 Nucleus 24. Magnetic Resonance Imaging. [cited 2016 6/12/16]. http://professionals.cochlearamericas.com/sites/default/files/resources/MRI.pdf . Accessed November 29, 2016
• 12 Walton J, Donnelly NP, Tam YC. , et al. MRI without magnet removal in neurofibromatosis type 2 patients with cochlear and auditory brainstem implants. Otol Neurotol 2014; 35 (05) 821-825
• 13 Medical Procedures for MED-EL Implant Systems. [cited 2016 6/12/2016]. http://s3.medel.com.s3.amazonaws.com/documents/AW/AW33290_30_Manual%20Medical%20Procedures%20-%20EN%20English%20US_web.pdf . Accessed November 29, 2016